Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community. The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care. Read More
Shares of healthcare professional network Doximity (NYSE:DOCS)
jumped 11.6% in the afternoon session after the company reported strong second-quarter 2025 results that surpassed Wall Street's expectations and raised its full-year guidance. The digital platform for U.S. medical professionals reported revenue of $145.9 million, an increase of 15.2% year over year, and adjusted earnings per share (EPS) of $0.36. These results comfortably beat analyst estimates, which called for $139.6 million in revenue and an adjusted EPS of $0.31. Furthermore, Doximity provided strong guidance for the next quarter, with its revenue forecast of $157.5 million coming in 5% above expectations. The company also raised its full-year revenue guidance to a midpoint of $632 million. The strong performance and optimistic outlook signaled healthy demand and operational efficiency, boosting investor confidence.
Healthcare professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 15.2% year on year to $145.9 million. On top of that, next quarter’s revenue guidance ($157.5 million at the midpoint) was surprisingly good and 5% above what analysts were expecting. Its non-GAAP profit of $0.36 per share was 17.2% above analysts’ consensus estimates.
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference.
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025.
A number of stocks fell in the afternoon session after the White House announced a new round of steep global tariffs, sparking concerns of a trade war and its impact on the U.S. and global economies. This move creates significant uncertainty for businesses and investors. The new tariffs, with rates of up to 41% on imports from 68 countries and the European Union, prompted a broad market sell-off, with the tech-heavy Nasdaq index showing notable weakness. Adding to the bearish sentiment was a weaker-than-expected July jobs report, which revealed that employers created only 73,000 jobs, far below economists' expectations. This combination of trade fears and signs of a slowing labor market has created a "risk-off" environment, leading investors to pull back from growth-oriented sectors like software and technology.
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight a healthcare workforce under pressure, with modest compensation growth of 3.7%, a persistent gender pay gap of 26%, and growing concern from pediatric physicians about declining reimbursement.
DOXIMITY INC (NYSE:DOCS) is a high-quality growth stock with strong profitability, zero debt, and exceptional capital efficiency, making it a standout pick for long-term investors.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Expensive stocks often command premium valuations because the market thinks their business models are exceptional.
However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.
DOXIMITY (NYSE:DOCS) combines strong earnings momentum with a bullish technical setup, making it a compelling candidate for growth investors. The stock shows robust EPS growth, expanding margins, and a favorable chart pattern.
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2025 after market close on August 7, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
